|3.39||-0.0200||-0.59%||Vol 37.81K||1Y Perf -69.55%|
|Feb 6th, 2023 16:00 DELAYED|
|- -||- -%|
|Target Price||5.00||Analyst Rating||Hold 3.00|
|Potential %||47.49||Finscreener Ranking||— -|
|Insiders Trans % 3/6/12 mo.||-/-/-||Value Ranking||+ 36.54|
|Insiders Value % 3/6/12 mo.||-/-/-||Growth Ranking||— -|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-||Income Ranking||— -|
|Price Range Ratio 52W %||20.76||Earnings Rating||Sell|
|Market Cap||126.20M||Earnings Date||30th Mar 2023|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Mngmt Effectiveness||Value||Industry||S&P 500||US Markets|
ROE (5Y Avg)
ROE last 12 Months
ROA (5Y Avg)
ROA last 12 Months
ROC (5Y Avg)
ROC last 12 Months
Return on invested Capital Q
Return on invested Capital Y
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||30th Mar 2023|
|Estimated EPS Next Report||-|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||40.58K|
|Avg. Monthly Volume||73.23K|
|Avg. Quarterly Volume||84.68K|
Pulse Biosciences Inc (NASDAQ: PLSE) stock closed at 3.39 per share at the end of the most recent trading day (a -0.59% change compared to the prior day closing price) with a volume of 37.81K shares and market capitalization of 126.20M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 82 people. Pulse Biosciences Inc CEO is Darrin R. Uecker.
The one-year performance of Pulse Biosciences Inc stock is -69.55%, while year-to-date (YTD) performance is 22.38%. PLSE stock has a five-year performance of -82.13%. Its 52-week range is between 1.18 and 11.825, which gives PLSE stock a 52-week price range ratio of 20.76%
Pulse Biosciences Inc currently has a PE ratio of -1.40, a price-to-book (PB) ratio of 17.02, a price-to-sale (PS) ratio of 168.55, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -89.61%, a ROC of -91.81% and a ROE of -279.39%. The company’s profit margin is -%, its EBITDA margin is -4 082.80%, and its revenue ttm is $709.00 Thousand , which makes it $0.02 revenue per share.
Of the last four earnings reports from Pulse Biosciences Inc, there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Pulse Biosciences Inc’s next earnings report date is 30th Mar 2023.
The consensus rating of Wall Street analysts for Pulse Biosciences Inc is Hold (3), with a target price of $5, which is +47.49% compared to the current price. The earnings rating for Pulse Biosciences Inc stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Pulse Biosciences Inc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Pulse Biosciences Inc has a Buy technical analysis rating based on Technical Indicators (ADX : 25.97, ATR14 : 0.25, CCI20 : 74.77, Chaikin Money Flow : 0.22, MACD : 0.14, Money Flow Index : 37.26, ROC : 3.65, RSI : 60.32, STOCH (14,3) : 53.30, STOCH RSI : 1.00, UO : 46.38, Williams %R : -46.70), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Pulse Biosciences Inc in the last 12-months were: Darrin R. Uecker (Option Excercise at a value of $0), Kevin Danahy (Buy at a value of $14 950), Mahkam Zanganeh (Option Excercise at a value of $0), Mitchell E. Levinson (Buy at a value of $69 908), Mitchell E. Levinson (Option Excercise at a value of $0), Robert W. Duggan (Option Excercise at a value of $0)
Sat, 12 Nov 2022 19:45 GMT Pulse Biosciences (PLSE) Gets a Hold from Maxim Group- TipRanks. All rights reserved.
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.